CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Louisville, Kentucky, United States and 56 other locations
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
Louisville, Kentucky, United States and 47 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Louisville, Kentucky, United States and 177 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Louisville, Kentucky, United States and 654 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Louisville, Kentucky, United States and 71 other locations
index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...
Phase 3
Louisville, Kentucky, United States and 146 other locations
in combination with a basal insulin (i.e., the Rapid-acting Insulin Analog \[RAA\] injection group) in pediatric subjects with type 1 or type 2 diabetes...
Phase 3
Louisville, Kentucky, United States and 38 other locations
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic...
Phase 2
Louisville, Kentucky, United States and 93 other locations
at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...
Phase 2
Louisville, Kentucky, United States and 78 other locations
This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. P...
Phase 3
Louisville, Kentucky, United States and 169 other locations
Clinical trials
Research sites
Resources
Legal